Valerie Mizrahi
#53,521
Most Influential Person Now
South African biologist
Valerie Mizrahi's AcademicInfluence.com Rankings
Valerie Mizrahibiology Degrees
Biology
#2852
World Rank
#4459
Historical Rank
Microbiology
#404
World Rank
#456
Historical Rank
Molecular Biology
#682
World Rank
#699
Historical Rank
Download Badge
Biology
Valerie Mizrahi's Degrees
- Bachelors Biological Sciences University of Cape Town
- Masters Microbiology University of Pretoria
- PhD Molecular Biology Stellenbosch University
Why Is Valerie Mizrahi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Valerie Mizrahi is a South African molecular biologist. Biography The daughter of Morris and Etty Mizrahi, she was born in Harare, Zimbabwe and was educated there. Her family is a Sephardi Jewish family from the Greek island of Rhodes.
Valerie Mizrahi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mycobacterium tuberculosis. (2018) (720)
- DnaE2 Polymerase Contributes to In Vivo Survival and the Emergence of Drug Resistance in Mycobacterium tuberculosis (2003) (386)
- The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice (2003) (363)
- The Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival (2000) (342)
- Kinetic mechanism of DNA polymerase I (Klenow). (1987) (305)
- The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro (2007) (305)
- Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration (2005) (276)
- The Mycobacterium tuberculosis protein serine/threonine kinase PknG is linked to cellular glutamate/glutamine levels and is important for growth in vivo (2004) (241)
- Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. (2012) (234)
- Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids (2008) (224)
- Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories (2010) (213)
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis (2013) (199)
- DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? (1998) (184)
- Mutants of Mycobacterium tuberculosis Lacking Three of the Five rpf-Like Genes Are Defective for Growth In Vivo and for Resuscitation In Vitro (2005) (170)
- Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling. (2010) (169)
- Mycobacterium tuberculosis and the host response (2005) (164)
- Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy (2006) (141)
- Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I (2002) (140)
- Function of the Cytochrome bc1-aa3 Branch of the Respiratory Network in Mycobacteria and Network Adaptation Occurring in Response to Its Disruption (2005) (118)
- Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening. (2012) (112)
- The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin? (2014) (112)
- Essential roles for imuA′- and imuB-encoded accessory factors in DnaE2-dependent mutagenesis in Mycobacterium tuberculosis (2010) (110)
- Rate-limiting steps in the DNA polymerase I reaction pathway. (1985) (109)
- VapC Toxins from Mycobacterium tuberculosis Are Ribonucleases that Differentially Inhibit Growth and Are Neutralized by Cognate VapB Antitoxins (2011) (108)
- Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment (2018) (104)
- Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis (2014) (101)
- Characterization of thecydAB-Encoded Cytochrome bd Oxidase fromMycobacterium smegmatis (2001) (94)
- Global expression profiling of strains harbouring null mutations reveals that the five rpf-like genes of Mycobacterium tuberculosis show functional redundancy. (2004) (91)
- Production of mutants in amino acid biosynthesis genes of Mycobacterium tuberculosis by homologous recombination. (1999) (91)
- Construction and Phenotypic Characterization of an Auxotrophic Mutant of Mycobacterium tuberculosis Defective in l-Arginine Biosynthesis (2002) (87)
- Kinetic mechanism of DNA polymerase I (1987) (83)
- Lack of mismatch correction facilitates genome evolution in mycobacteria (2004) (80)
- The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis (2016) (78)
- The complex mechanism of antimycobacterial action of 5-fluorouracil. (2015) (77)
- Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities. (1989) (75)
- Ribonucleotide Reduction in Mycobacterium tuberculosis: Function and Expression of Genes Encoding Class Ib and Class II Ribonucleotide Reductases (2003) (75)
- A vitamin B12 transporter in Mycobacterium tuberculosis (2013) (73)
- A Riboswitch Regulates Expression of the Coenzyme B12-Independent Methionine Synthase in Mycobacterium tuberculosis: Implications for Differential Methionine Synthase Function in Strains H37Rv and CDC1551 (2007) (73)
- Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis. (2017) (73)
- The survival kit of Mycobacterium tuberculosis (2007) (66)
- Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (2016) (61)
- Purification, Gene Cloning, Targeted Knockout, Overexpression, and Biochemical Characterization of the Major Pyrazinamidase fromMycobacterium smegmatis (1998) (56)
- Role of the DinB Homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis (2010) (56)
- Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents. (2014) (53)
- Identification and validation of novel drug targets in Mycobacterium tuberculosis. (2017) (53)
- Diversity and disease pathogenesis in Mycobacterium tuberculosis. (2015) (53)
- Shortening treatment for tuberculosis--to basics. (2014) (52)
- Expression of Mycobacterium smegmatisPyrazinamidase in Mycobacterium tuberculosis Confers Hypersensitivity to Pyrazinamide and Related Amides (2000) (52)
- Functional Analysis of Molybdopterin Biosynthesis in Mycobacteria Identifies a Fused Molybdopterin Synthase in Mycobacterium tuberculosis (2010) (52)
- Vitamin B(12) metabolism in Mycobacterium tuberculosis. (2013) (50)
- Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients. (2017) (50)
- Construction by homologous recombination and phenotypic characterization of a DNA polymerase domain polA mutant of Mycobacterium smegmatis. (1996) (48)
- Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis (2016) (48)
- SOS induction in mycobacteria: analysis of the DNA‐binding activity of a LexA‐like repressor and its role in DNA damage induction of the recA gene from Mycobacterium smegmatis (1997) (47)
- Mechanism of DNA polymerase I: exonuclease/polymerase activity switch and DNA sequence dependence of pyrophosphorolysis and misincorporation reactions. (1986) (47)
- Function and Regulation of Class I Ribonucleotide Reductase-Encoding Genes in Mycobacteria (2008) (46)
- Synthesis, Characterization, and Pharmacological Evaluation of Silicon-Containing Aminoquinoline Organometallic Complexes As Antiplasmodial, Antitumor, and Antimycobacterial Agents (2013) (45)
- Molybdenum cofactor: A key component of Mycobacterium tuberculosis pathogenesis? (2014) (45)
- DNA Alkylation Damage as a Sensor of Nitrosative Stress in Mycobacterium tuberculosis (2003) (45)
- Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis. (2006) (43)
- Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase. (1990) (42)
- Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c (2017) (42)
- Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity. (1991) (41)
- Deoxy- and dideoxynucleotide discrimination and identification of critical 5' nuclease domain residues of the DNA polymerase I from Mycobacterium tuberculosis. (1996) (41)
- Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis (2018) (40)
- Molecular genetics of Mycobacterium tuberculosis in relation to the discovery of novel drugs and vaccines. (2004) (38)
- Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents. (2018) (38)
- Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis (2017) (37)
- Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis. (1994) (37)
- Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC) (2016) (37)
- Detection and treatment of subclinical tuberculosis. (2012) (36)
- 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization (2018) (36)
- Characterization of the cydAB -Encoded Cytochrome bd Oxidase from Mycobacterium smegmatis (2001) (36)
- Transmission of drug-resistant tuberculosis in HIV-endemic settings. (2019) (34)
- The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis (2015) (34)
- Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery (2016) (33)
- A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis (2013) (32)
- Complex genetics of drug resistance in Mycobacterium tuberculosis (2013) (31)
- Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes (2020) (29)
- Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents. (2018) (27)
- In Vitro Analysis of Rates and Spectra of Mutations in a Polymorphic Region of the Rv0746 PE_PGRS Gene of Mycobacterium tuberculosis (2006) (26)
- The Influence of HIV on the Evolution of Mycobacterium tuberculosis (2017) (26)
- Staphylococcus aureus nuclease is a useful secretion reporter for mycobacteria. (1999) (25)
- Nucleotide Metabolism and DNA Replication. (2014) (24)
- Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis (2016) (24)
- Analysis of the ribonuclease H activity of HIV-1 reverse transcriptase using RNA.DNA hybrid substrates derived from the gag region of HIV-1. (1989) (22)
- Cloning and sequence analysis of the gene encoding the DNA polymerase I from Mycobacterium tuberculosis. (1995) (21)
- Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients (2018) (21)
- IS1096-mediated DNA rearrangements play a key role in genome evolution of Mycobacterium smegmatis. (2008) (20)
- Identification of aminopyrimidine‐sulfonamides as potent modulators of Wag31‐mediated cell elongation in mycobacteria (2017) (20)
- The Tuberculosis Drug Accelerator at year 10: what have we learned? (2021) (20)
- TB tools to tell the tale-molecular genetic methods for mycobacterial research. (2005) (20)
- Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis. (2010) (19)
- Foam Cells Control Mycobacterium tuberculosis Infection (2020) (18)
- Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols. (2021) (18)
- Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies (2017) (18)
- Phosphoric carboxylic imides. I. Preparation and fragmentation behavior of dialkylphosphoryl (and phosphinyl) acetyl (and benzoyl) imides and related systems (1982) (18)
- A PCR method for the sequence analysis of the gyrA, polA and rnhA gene segments from mycobacteria. (1993) (17)
- Setting Our Sights on Infectious Diseases (2019) (17)
- The dynamics of DNA polymerase-catalyzed reactions. (1988) (17)
- DNA metabolism in Mycobacterium leprae. (2001) (17)
- Cloning, sequence analysis, overproduction in Escherichia coli and enzymatic characterization of the RNase HI from Mycobacterium smegmatis. (1995) (17)
- Mechanism of the idling-turnover reaction of the large (Klenow) fragment of Escherichia coli DNA polymerase I. (1986) (17)
- Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. (2014) (16)
- bis-Molybdopterin Guanine Dinucleotide Is Required for Persistence of Mycobacterium tuberculosis in Guinea Pigs (2014) (16)
- The Coming of Age of Drug-Susceptibility Testing for Tuberculosis. (2018) (16)
- Synthesis and Structure–Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH (2019) (15)
- COVID-19 research in Africa (2020) (15)
- N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis (2017) (14)
- Construction and application of mycobacterial reporter transposons. (2000) (14)
- DNA metabolism in mycobacterial pathogenesis. (2013) (14)
- A derivative of Mycobacterium smegmatis mc(2)155 that lacks the duplicated chromosomal region. (2006) (13)
- Phosphoric-carboxylic imides. 2. Solvolytic cleavage of the nitrogen-carbonyl and nitrogen-phosphoryl bonds (1983) (13)
- Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery (2019) (13)
- The carbon starvation-inducible genes Rv2557 and Rv2558 of Mycobacterium tuberculosis are not required for long-term survival under carbon starvation and for virulence in SCID mice. (2006) (11)
- DNA metabolism in mycobacterium tuberculosis: implications for drug resistance and strain variability. (2001) (10)
- Targeted gene knockout and essentiality testing by homologous recombination. (2015) (10)
- Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium tuberculosis (2019) (9)
- Rapid kinetic analysis of a point mutant of HIV-1 reverse transcriptase lacking ribonuclease H activity. (1993) (9)
- Mycobacterial genetics in target validation. (2004) (9)
- Death of Mycobacterium tuberculosis by l-arginine starvation (2018) (9)
- Endoribonucleolytic cleavage of RNA: oligodeoxynucleotide hybrids by the ribonuclease H activity of HIV-1 reverse transcriptase. (1990) (8)
- DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis (2021) (8)
- DNA Replication Fidelity in the Mycobacterium tuberculosis Complex. (2017) (8)
- Cleavage of the moaX-encoded fused molybdopterin synthase from Mycobacterium tuberculosis is necessary for activity (2015) (7)
- Making ends meet in mycobacteria (2011) (7)
- Resuscitation promoting factors in bacterial population dynamics during TB infection (2010) (7)
- Alkylation of ambident ions derived from phosphoric–carboxylic imides. N-Benzoyl-O,O-dimethyl-O-ethylphosphorimidate and E/ZO-ethyl-N-(dimethylphosphoryl)benzimidate (1983) (7)
- A Pseudokinase Debut at the Mycobacterial Cell Wall (2012) (6)
- Renewing the Fight Against TB with an Old Vaccine (2020) (6)
- De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis (2020) (6)
- 6,11-Dioxobenzo[f]pyrido[1,2-a]indoles kill Mycobacterium tuberculosis by targeting iron-sulfur protein Rv0338c (IspQ) a putative redox sensor. (2020) (5)
- Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis (2020) (5)
- Approaches to target identification and validation for tuberculosis drug discovery: a UCT perspective. (2012) (5)
- Physiology of Mycobacterium tuberculosis (2017) (5)
- Translating genomics research into control of tuberculosis: lessons learned and future prospects (2014) (5)
- Expanding the anti-TB arsenal (2019) (4)
- Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site (2019) (4)
- The mycobacterial mutasome: composition and recruitment in live cells (2021) (4)
- The RLEP-flanked polA gene from Mycobacterium leprae is not transcribed in Mycobacterium smegmatis. (1997) (4)
- Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria (2021) (4)
- Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis bioaerosols (2019) (4)
- Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH. (2019) (4)
- Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site (2021) (4)
- PHOSPHORIC-CARBOXYLIC IMIDES. III. THE BENZOYLATION OF N-METHYLDIETHYL-PHOSPHORAMIDATE AND RELATED ANIONS (1984) (4)
- Shortening the Short Course of Tuberculosis Treatment. (2021) (4)
- Tuberculosis research--the way forward. (1996) (3)
- Genetics and tuberculosis, Cape Town, South Africa, 21 November 1997. (1997) (3)
- Highlights from the first meeting of the Europe-Africa frontier research conference series infectious diseases: from basic to translational research. (2010) (3)
- Mutational dynamics in Mycobacterium tuberculosis: implications for the evolution of drug resistance (2004) (3)
- Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases (2021) (2)
- Tuberculosis and the Tubercle Bacillus, Second Edition (2017) (2)
- Nucleic Acid Metabolism (2005) (2)
- Structure - Reactivity of Mixed Carboxylic Phosphoric Imides (1983) (2)
- Chemical validation of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase using fragment linking and CRISPR interference (2020) (2)
- Approaches to target identification and validation for tuberculosis drug discovery : a University of Cape Town perspective : forum - review (2012) (2)
- RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria (2021) (1)
- A novel inducible mutagenesis system in Mycobacterium tuberculosis (2012) (1)
- Phosphoric–carboxylic imides. Part 4. MNDO molecular orbital calculations on N-formylphosphinamide, H2P(O)NHCHO, and related systems (1984) (1)
- PHOSPHORIC-CARBOXYLIC IMIDES. III. THE BENZOYLATION OF N-METHYLDIETHYLPHOSPHORAMIDATE AND RELATED ANIONS (1985) (1)
- Paper Data: Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients (October 2017) (2017) (1)
- Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity (2021) (1)
- Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis (2022) (1)
- A platform for genomics in South Africa. (2001) (1)
- STABILITY AND EXPRESSION IN BACILLUS SUBTILIS OF AN α-AMYLASE HYBRID PLASMID (1988) (1)
- Hit movie reveals how a tuberculosis drug halts ATP synthesis (2020) (1)
- Corrigendum: Foam Cells Control Mycobacterium tuberculosis Infection (2020) (1)
- Dormancy and Low-Growth States in Microbial Disease: Mechanisms of stationary-phase mutagenesis in bacteria and their relevance to antibiotic resistance (2003) (1)
- Correction for Arora et al., “Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis” (2017) (1)
- The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition (2023) (0)
- Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents. (2021) (0)
- Challenges in TB research (2022) (0)
- The structure and reactivity of N-Acyl phosphoric amides and related systems (1983) (0)
- Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant 1 Mycobacterium tuberculosis 2 ( Running title : Restoring sensitivity in drug-resistant tuberculosis ) 3 (2019) (0)
- Susceptibility of cytochrome oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome . (2017) (0)
- The crystal and molecular structures of dibenzimide and itsN-methylated analogue: steric and hydrogen-bonding effects (1984) (0)
- Identifying vulnerable steps in the coenzyme A biosynthesis pathway of M. tuberculosis (2016) (0)
- The Role of Resuscitation Promoting Factors in the Virulence of Mycobacterium tuberculosis (2007) (0)
- A19 The impact of HIV-1 on the evolution of Mycobacterium tuberculosis (2018) (0)
- Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis” (2022) (0)
- Big Questions in Microbiology (2017) (0)
- Research data supporting "A fragment-based approach to targeting IMPDH from Mycobacterium tuberculosis" (2018) (0)
- among HIV-1 patients in Israel, (2018) (0)
- Hit movie reveals how a tuberculosis drug halts ATP synthesis (2020) (0)
- Translating genomics research into control of tuberculosis: lessons learned and future prospects (2014) (0)
- Electron Impact Fragmentation Behavior of Phosphoric — Carboxylic Imides and Related Systems (2010) (0)
- Tuberculosis Drug Discovery: Target Identification and Validation (2012) (0)
- PHOSPHORIC-CARBOXYLIC IMIDES. 2. SOLVOLYTIC CLEAVAGE OF THE NITROGEN-CARBONYL L AND NITROGEN-PHOSPHORYL BONDS (1984) (0)
- PHOSPHORIC-CARBOXYLIC IMIDES. PART 4. MNDO MOLECULAR ORBITAL CALCULATIONS ON N-FORMYLPHOSPHINAMIDE AND RELATED SYSTEMS (1984) (0)
- Cleavage of the moaX-encoded fused molybdopterin synthase from Mycobacterium tuberculosis is necessary for activity (2015) (0)
- Investigation into the nature of a Bacillus promoter cloned into a promoter-probe plasmid. (1989) (0)
- Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant <named-content content-type='genus-species'>Mycobacterium tuberculosis</named-content> (2021) (0)
- Mechanistic Studies on DNA Polymerase I (1988) (0)
This paper list is powered by the following services:
Other Resources About Valerie Mizrahi
What Schools Are Affiliated With Valerie Mizrahi?
Valerie Mizrahi is affiliated with the following schools:
